Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FCMZG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,311
Award facts
- Contract value 100% obligated
- $4,311.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation was applied to this award.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, valued at $499,999,999 and effective through November 2026. The parent IDC establishes DMS Pharmaceutical Group as a primary federal supplier for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. Xtandi, an oncology therapeutic, represents a specialized pharmaceutical product within the contractor's portfolio of medical supplies distributed to military health systems. This delivery order exemplifies the ongoing pharmaceutical supply chain support DMS Pharmaceutical Group provides to federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FCMZG?
SPE2DB25FCMZG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FCMZG worth?
The government has obligated $4,311 on SPE2DB25FCMZG.
Is contract SPE2DB25FCMZG an order under another contract?
Yes. SPE2DB25FCMZG is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZG competed?
The extent of competition for SPE2DB25FCMZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award